Is defined as an intervention intended to prevent or reduce the probability of the occurrence of an adverse reaction associated with the exposure to a medicine, or to reduce its severity should it occur. These activities may consist of routine risk minimization (e.g. product information) or additional risk minimization activities (e.g. healthcare professional or patient communications/educational materials etc…).